PFIZER CANADA ULC/PFIZER CANADA SRI
Registration:
45
of
47
(2024-12-09
to
2024-12-09)
Details Regarding the Identified Subject Matter
|
Specific Topics of Lobbying Communications
|
Intended Outcomes
|
Associated Subject Matters
|
Discuss Product Listing Agreements of Pfizer Innovative Medicine products with BC Pharmacare
|
Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity
|
Health
|
Recommendations regarding job creation and growth of BC's knowledge-based economy. Business incentives for and/or barriers to investment in BC. Sharing of information on Pfizer's global research investment platform and opportunities for increase investment in BC.
|
Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity
|
Economic Development and Trade, Science and Technology
|
Seeking reimbursement for Pfizer oncology medicines through the BC Cancer systemic drug therapy program under the Provincial Health Services Authority
|
Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity
|
Health
|
Through Innovative Medicines of Canada (IMC) to further promote the contributions and positive impact of the pharmaceutical industry in British Columbia and to increase awareness of the value of innovative therapies on the healthcare system.
|
Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity
|
Health
|